Varex Imaging CORP 8-K filings

Teledyne Technologies Incorporated announced a definitive agreement to acquire Varex Imaging Corporation for $18.90 per share in cash, valuing the deal at approximately $1.1 billion.

Varex Imaging announced third quarter fiscal year 2026 results, showing a 4% year-over-year revenue increase to $210.5 million, driven by strong industrial segment growth, alongside improved gross margins.

Varex Imaging Corporation successfully refinanced $368 million in senior secured notes with a new $490 million credit facility, expecting over $7 million in annual cash interest savings.

Varex Imaging Corporation announced preliminary first quarter fiscal year 2026 financial results, reporting revenues of $210 million and non-GAAP diluted EPS of $0.19, exceeding guidance expectations.

Varex Imaging Corporation announced robust fourth-quarter and fiscal year 2025 financial results, driven by strong medical and industrial segment performance.

Varex Imaging Corporation announced that Kimberley Honeysett, its Senior Vice President, Chief Legal Officer, and Corporate Secretary, will transition out of her role, remaining as an advisor until December 2027.

Varex Imaging Corporation reported third-quarter fiscal year 2025 revenues of $203 million, exceeding guidance, despite a significant GAAP net loss driven by a goodwill impairment charge.

Varex Imaging Corporation announced a 3% year-over-year revenue increase for Q2 fiscal year 2025, but lowered its short-term outlook due to high tariffs imposed by China.

Varex Imaging Corporation acknowledges an anti-dumping investigation by China's Ministry of Commerce (MOFCOM) into imports of certain medical CT X-ray tubes originating from the United States and India.

Varex Imaging Corporation's stockholders approved an amendment to the company's charter to limit the monetary liability of certain officers for breaches of fiduciary duty of care, effective immediately upon filing on February 13, 2025.

Varex Imaging Corporation announces its first quarter fiscal year 2025 financial results, with revenue reaching $200 million, a 5% increase year-over-year, and improved profitability.

Varex Imaging Corporation terminated a $20 million equipment credit agreement with Zions Bancorporation after securing funding through a senior secured notes offering.

Varex Imaging Corporation successfully completed a $125 million private offering of senior secured notes to partially repay convertible notes due in 2025.

Varex Imaging Corporation has announced a private offering of $125 million in senior secured notes to partially repay its convertible notes due in 2025.

Varex Imaging Corporation announced its fourth quarter and full fiscal year 2024 results, with revenue at the high end of guidance but a year-over-year decrease in both revenue and earnings.

Varex Imaging Corporation has amended its senior secured revolving credit agreement to allow for greater flexibility in making restricted payments and calculating financial ratios.

Varex Imaging Corporation announced its third quarter fiscal year 2024 results, with a revenue decrease of 10% year-over-year, but a 6% increase in the Industrial segment.

Varex Imaging Corporation announced its second quarter fiscal year 2024 results, with revenue in line with guidance but down year-over-year, and lowered its outlook for the second half of the year due to continued weakness in the medical segment, particularly in China.

Varex Imaging Corporation has closed a new $155 million senior secured revolving credit facility, replacing its existing credit agreement and bolstering its liquidity.

Varex Imaging Corporation held its 2024 Annual Meeting of Stockholders on February 8, 2024, where key proposals including the election of directors and approval of the amended 2020 Omnibus Stock Plan were passed.

Varex Imaging Corporation announced its first quarter fiscal year 2024 results, with revenue meeting guidance but profitability impacted by unfavorable mix.